Literature DB >> 29696980

Enantioselective Synthesis of Thailanstatin A Methyl Ester and Evaluation of in Vitro Splicing Inhibition.

Arun K Ghosh1, Anne M Veitschegger1, Shenyou Nie1, Nicola Relitti1, Andrew J MacRae2, Melissa S Jurica2.   

Abstract

Thailanstatin A has been isolated recently from the fermentation broth of B. thailandensis MSMB43. We describe here an enantioselective convergent synthesis of thailanstatin A methyl ester and evaluation of its splicing activity. Synthesis of both highly functionalized tetrahydropyran rings were carried out from commercially available tri- O-acetyl-d-glucal as the key starting material. Our convergent synthesis involved the synthesis of both tetrahydropyran fragments in a highly stereoselective manner. The fragments were then coupled using cross-metathesis as the key step. The synthesis of the diene subunit included a highly stereoselective Claisen rearrangement, a Cu(I)-mediated conjugate addition of MeLi to set the C-14 methyl stereochemistry, a reductive amination reaction to install the C16-amine functionality, and a Wittig olefination reaction to incorporate the diene unit. The epoxy alcohol subunit was synthesized by a highly selective anomeric allylation, a Peterson olefination, and a vanadium catalyzed epoxidation that installed the epoxide stereoselectively. Cross-metathesis of the olefins provided the methyl ester derivative of thailanstatin A. We have carried out in vitro splicing studies of the methyl ester derivative, which proved to be a potent inhibitor of the spliceosome.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29696980      PMCID: PMC5972027          DOI: 10.1021/acs.joc.8b00593

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  41 in total

Review 1.  The spliceosome: design principles of a dynamic RNP machine.

Authors:  Markus C Wahl; Cindy L Will; Reinhard Lührmann
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

2.  New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  H Nakajima; B Sato; T Fujita; S Takase; H Terano; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

3.  Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing.

Authors:  Liying Fan; Chandraiah Lagisetti; Carol C Edwards; Thomas R Webb; Philip M Potter
Journal:  ACS Chem Biol       Date:  2011-03-07       Impact factor: 5.100

4.  Total synthesis of FR901464, an antitumor agent that regulates the transcription of oncogenes and tumor suppressor genes.

Authors:  Brian J Albert; Ananthapadmanabhan Sivaramakrishnan; Tadaatsu Naka; Kazunori Koide
Journal:  J Am Chem Soc       Date:  2006-03-08       Impact factor: 15.419

5.  Enantioselective total synthesis of (-)-zampanolide, a potent microtubule-stabilizing agent.

Authors:  Arun K Ghosh; Xu Cheng
Journal:  Org Lett       Date:  2011-07-12       Impact factor: 6.005

Review 6.  The spliceosome as a target of novel antitumour drugs.

Authors:  Sophie Bonnal; Luisa Vigevani; Juan Valcárcel
Journal:  Nat Rev Drug Discov       Date:  2012-11       Impact factor: 84.694

7.  Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs.

Authors:  Kerstin A Effenberger; David D Anderson; Walter M Bray; Beth E Prichard; Nianchun Ma; Matthew S Adams; Arun K Ghosh; Melissa S Jurica
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

8.  Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43.

Authors:  Xiangyang Liu; Sreya Biswas; Michael G Berg; Christopher M Antapli; Feng Xie; Qi Wang; Man-Cheng Tang; Gong-Li Tang; Lixin Zhang; Gideon Dreyfuss; Yi-Qiang Cheng
Journal:  J Nat Prod       Date:  2013-03-21       Impact factor: 4.050

9.  Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.

Authors:  Chandraiah Lagisetti; Maria V Yermolina; Lalit Kumar Sharma; Gustavo Palacios; Brett J Prigaro; Thomas R Webb
Journal:  ACS Chem Biol       Date:  2013-12-30       Impact factor: 5.100

10.  High antitumor activity of pladienolide B and its derivative in gastric cancer.

Authors:  Momoko Sato; Naoki Muguruma; Tadahiko Nakagawa; Koichi Okamoto; Tetsuo Kimura; Shinji Kitamura; Hiromi Yano; Katsutaka Sannomiya; Takahiro Goji; Hiroshi Miyamoto; Toshiya Okahisa; Hiroaki Mikasa; Satoshi Wada; Masao Iwata; Tetsuji Takayama
Journal:  Cancer Sci       Date:  2013-12-04       Impact factor: 6.716

View more
  6 in total

1.  Burkholderia as a Source of Natural Products.

Authors:  Sylvia Kunakom; Alessandra S Eustáquio
Journal:  J Nat Prod       Date:  2019-07-11       Impact factor: 4.050

2.  Convergent Synthesis of the C1-C29 Framework of Amphidinolide F.

Authors:  Filippo Romiti; Ludovic Decultot; J Stephen Clark
Journal:  J Org Chem       Date:  2022-06-08       Impact factor: 4.198

3.  Copper-Catalyzed Stille Cross-Coupling Reaction and Application in the Synthesis of the Spliceostatin Core Structure.

Authors:  Arun K Ghosh; Joshua R Born; Anne M Veitschegger; Melissa S Jurica
Journal:  J Org Chem       Date:  2020-06-09       Impact factor: 4.354

4.  Design and synthesis of herboxidiene derivatives that potently inhibit in vitro splicing.

Authors:  Arun K Ghosh; Srinivasa Rao Allu; Guddeti Chandrashekar Reddy; Adriana Gamboa Lopez; Patricia Mendez; Melissa S Jurica
Journal:  Org Biomol Chem       Date:  2021-02-18       Impact factor: 3.876

Review 5.  Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.

Authors:  Arun K Ghosh; Jennifer L Mishevich; Melissa S Jurica
Journal:  J Nat Prod       Date:  2021-05-11       Impact factor: 4.803

6.  Total Synthesis of Limaol.

Authors:  Stephan N Hess; Xiaobin Mo; Conny Wirtz; Alois Fürstner
Journal:  J Am Chem Soc       Date:  2021-02-03       Impact factor: 15.419

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.